@FiercePharma: Sanofi workers to strike as day of reckoning nears. More | Follow @FiercePharma
> An analysis of 133 print and broadcasting ads for four different medicines that were switched to over-the-counter sales found that more of them touted benefits after the switch than when they were sold by prescription. Story
> Danish drugmaker Lundbeck says it will get a new meeting with the FDA next year for the resubmission for its schizophrenia treatment, aripiprazole depot formulation. Story
> Aurobindo Pharma has final approval from the FDA to make and market a generic of Forest Laboratories' anti-depressant Lexapro. Item
> The DEA will revoke the license of two CVS drugstores in Florida over "suspicious sales" of oxycodone and other painkillers. Story
> Pfizer ($PFE) is using a new cloud-based software system for its supply chain operations. Story
Biotech News
@FierceBiotech: D-Day for Sanofi multiples cerlosis drug Aubagio as deep R&D cuts loom. Story | Follow @FierceBiotech
@JohnCFierce: Lundbeck, Otsuka scramble to get antipsychotic back on FDA track--(competing with Alkermes). Article | Follow @JohnCFierce
@RyanMFierce: My take on Illumina's alliance with Partners HealthCare to combine sequencing and software. Story | Follow @RyanMFierce
> UNC biotech spinoff grabs J&J deal and $16M A round for diabetic nephropathy drug. Story
> GlaxoSmithKline anti-smoking drug combats addictive cravings. Report
> Sanofi's dengue fever vaccine trial flop rattles the experts. News
@FierceMedDev: J&J has settled the first three lawsuits involving failure of its ASR hip implants. Thousands more to come. Release | Follow @FierceMedDev
@MarkHFierce: bioMerieux got slapped with an FDA warning letter for quality violations regarding a NC Dx manufacturing facility. Warning Letter | Follow @MarkHFierce
@DamianFierce: Berkeley's Ekso Bionics is looking to expand the use of its robotic walking aid. Report | Follow @DamianFierce
> IntraPace preps anti-obesity device for U.S. regulatory path. More
> PrimeraDx snags CE marks for assays. News
Biomarkers News
> Janssen's Remicade attacks inflammation to beat depression. Article
> Increased antibody levels tag raised rheumatoid arthritis risk. Story
> Researchers develop genetic test to fine-tune warfarin dose. Item
> Breast cancer protein pinpoints survival chances. More
Drug Delivery News
> Hopkins cracks blood-brain barrier with nanobeads. More
> Sublingual opioid addiction therapy moves closer to market. Report
> Silence breaks out with preclinical data on Atu111. Story
> InSite eyes next-generation DuraSite delivery. Article
> Anti-HIV vaginal ring shows hints of efficacy. More
> AZ goes Down Under for cancer conjugate deal. Item
And Finally... Cosmetics behemoth Lancôme has received a warning letter from the FDA over what the agency says are unacceptable medical claims for some its anti-aging creams, such as that they boost "the activity of genes and stimulates the production of youth proteins." Warning letter